✦ LIBER ✦

Retrospective exploratory analysis ofVEGFpolymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer

✍ Scribed by Fotios Loupakis; Annamaria Ruzzo; Lisa Salvatore; Chiara Cremolini; Gianluca Masi; Paolo Frumento; Marta Schirripa; Vincenzo Catalano; Nadia Galluccio; Emanuele Canestrari; Bruno Vincenzi; Daniele Santini; Katia Bencardino; Vincenzo Ricci; Mariangela Manzoni; Marco Danova; Giuseppe Tonini; Mauro Magnani; Alfredo Falcone; Francesco Graziano

Book ID: 119897167
Publisher: BioMed Central
Year: 2011
Tongue: English
Weight: 624 KB
Volume: 11
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-11-247

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6115 VEGF gene polymorphisms in the pred

6115 VEGF gene polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab (BV) in metastatic colorectal cancer (mCRC) patients (pts)

✍ Loupakis, F.; Ruzzo, A.; Salvatore, L.; Canestrari, E.; Cremolini, C.; Santini, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Predictors of the efficacy of FOLFIRI pl

Predictors of the efficacy of FOLFIRI plus bevacizumab as second-line treatment in metastatic colorectal cancer patients

✍ Mitsukuni Suenaga; Satoshi Matsusaka; Masashi Ueno; Noriko Yamamoto; Eiji Shinoz 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 148 KB

PCN69 COST-EFFECTIVENESS OF FIRST-LINE C

PCN69 COST-EFFECTIVENESS OF FIRST-LINE COMBINATION TREATMENT WITH BEVACIZUMAB PLUS FOLFIRI VERSUS FOLFIRI IN PATIENTS WITH METASTATIC COLORECTAL CANCER: A UK PERSPECTIVE

✍ M Gyldmark; R Aultman; U Siebert; E Sabate 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

The Clinical Efficacy of FOLFIRI and Bev

The Clinical Efficacy of FOLFIRI and Bevacizumab in Combination as First-Line Therapy of Metastatic Colorectal Cancer

✍ Erin Grothey; Edward Chu 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 91 KB

An observational study of bevacizumab co

An observational study of bevacizumab combined with FOLFIRI as the first-line treatment in metastatic colorectal cancer

✍ Huang, Meng-Lin; Kan, Jung-Yu; Ma, Cheng-Jen; Huang, Ching-Wen; Chen, Fang-Ming; 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 261 KB

A retrospective observational study on t

A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer

✍ López, R; Salgado, M; Reboredo, M; Grande, C; Méndez, J C; Jorge, M; Romero, C; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 320 KB